Get your healthcare questions answered
by doctors, scientists, and clinical experts
A free service by Curio to support patients and their loved ones
Your team
I've been diagnosed with glioblastoma and I'm having difficulty processing this information. As a scientist, I'm looking for a deep, scientific understanding of my condition. Can you provide some recent studies or explain the current research on glioblastoma?
Anna(AI First Responder)••Verified by Curio clinicianI'm sorry to hear about your diagnosis. Glioblastoma is a highly aggressive and malignant form of brain cancer that affects the supportive tissues in the brain. While there is still much to learn about glioblastoma, researchers are working tirelessly to better understand the disease and improve treatment approaches.
As a scientist, you may be interested to know that recent research has focused on several areas related to glioblastoma, including:
-
Genetics: Studies have identified numerous genetic mutations that are implicated in the development and progression of glioblastoma. These mutations can help researchers to better understand the molecular mechanisms underlying the disease and may inform the development of targeted therapies.
-
Immunotherapy: Researchers are exploring new immunotherapeutic approaches for glioblastoma that involve stimulating the immune system to attack cancer cells. Recent studies have shown promising results with checkpoint inhibitors, CAR T-cell therapy, and other immunotherapeutic approaches.
-
Metabolism: Recent research has suggested that changes in cellular metabolism may play a significant role in glioblastoma development and progression. By studying these metabolic changes, researchers may be able to identify new therapeutic targets and develop novel treatments.
-
Biomarkers: Emerging research suggests that biomarkers may be useful for predicting glioblastoma prognosis and response to treatment. By identifying and validating these biomarkers, clinicians may be able to better tailor treatment approaches to individual patients.
While there is still much to learn about glioblastoma, these areas of research offer hope for new and more effective treatment options. Your healthcare team can provide you with more information on the latest research and potential treatment options. It is essential to work with a multidisciplinary team of healthcare professionals to come up with an individualised treatment plan to help you manage your condition.
-
- Carolina Estevao(Scientific Advisor)•
There are a few studies that you might find interesting to read Alex:
Regarding immunotherapy, initial results of immune checkpoint inhibitors for glioblastoma have been disappointing, and ongoing clinical trials are evaluating their efficacy in combination with other treatments. When it comes to vaccine therapies, such as rindopepimut and ICT-107, have shown some efficacy in glioblastoma, but further studies are needed to determine the optimal patient population and treatment regimens (1).
Another review found that oncolytic virus-mediated destruction of glioblastoma tissue, coupled with robust immune responses, shows potential as a potent immunotherapy against glioblastoma. Oncolytic viruses have a preference for selectively eliminating cancerous cells through both direct and indirect mechanisms. They achieve this by effectively engaging the immune cells responsible for targeting cancer cells (2).
There is also another study that I thought you might want to check out: Glioblastoma cells exhibit resistance to apoptosis, a process that leads to cell death. MicroRNAs (miRNAs) can regulate gene expression and affect cell biology pathways, including apoptosis. In this lab-based study, overexpression of miR-342 induced apoptosis in glioblastoma cells. This could mean that, in the future, miR-342 could serve as a potential therapeutic target for glioblastoma treatment (3).
Sources:
